J3375 HCPCS Level II code: Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg
J3375 is the HCPCS code for “Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3375Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg
Short description: Inj, vanco (tyzavan) 10mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J3375 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jul 1, 2025
Where J3375 sits
- 1J codesDrugs administered other than orally
- 2Active code J3375Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3375 mean?
J3375 is the HCPCS code for “Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3375?
CMS lists J3375’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3375
All J codesJ3365Injection, iv, urokinase, 250,000 i.u. vialJ3370Injection, vancomycin hcl, 500 mgJ3371Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mgJ3372Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mgJ3373Injection, vancomycin hydrochloride, 10 mgJ3374Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mgJ3376Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mgJ3379Injection, valproate sodium, 5 mgJ3380Injection, vedolizumab, intravenous, 1 mgJ3385Injection, velaglucerase alfa, 100 unitsJ3386Injection, etuvetidigene autotemcel, per treatmentJ3387Injection, elivaldogene autotemcel, per treatment